Yahoo Web Search

  1. Fasenra will compete with GlaxoSmithKline's Nucala and Teva's Cinqair — two other injectable antibody drugs for severe asthma — but AstraZeneca believes its product's potency and convenient ...

  2. Roche Holding AG, facing pressure in Europe as cheaper biosimilars of its three biggest cancer medicines chew away at its revenue, sued to block Pfizer Inc. from selling a copy of its breast-cancer ...

  3. Arsanis Inc.

    Market Watch5 hours ago

    Arsanis Inc. stock price, stock quotes and financial overviews from MarketWatch.

  4. The single-use harvesting platform features a 4-layer concept, and has been optimized to maintain performance as cell density and viability change to minimize the impact of process variability ...

  5. LUND, Sweden, Nov. 21, 2017 /PRNewswire/ -- Alligator Bioscience (nasdaq stockholm:ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy ...

  6. Investors in Wall Street's long-running bull market are obviously a very happy bunch. Indeed, recent trends have fueled rallies in Europe and the emerging markets, analysts point out, although ...

  7. The "Antibody Drug Conjugates Market (4th Edition) 2017-2030" report has been added to Research and Markets' offering. The Antibody Drug Conjugates Market (4th Edition), 2017-2030 ...

  8. ASNS, +3.80% a clinical-stage biopharmaceutical company focused on applying monoclonal antibody immunotherapies to address serious infectious diseases, today announced the closing of ...

  9. An important new study examines the safety and efficacy of VRC01, a broadly neutralizing anti-HIV antibody, when administered as a long-term HIV prevention method. While earlier VRC01 ...

  10. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies and cancer vaccines, today announced the receipt of a $4 million payment for the advancement ...

  1. 12345240 results